PlayBeyondBio is a platform where the world’s leading ecosystem players
team up to supercharge your digital health startup.
PlayBeyondBio is a JVP, AstraZeneca and ii2020 partnership, in collaboration with
PlayBeyondBio is a platform created for disruptive digital health companies building innovative products. Our partners have teamed up to put their knowledge, resources and market access at your disposal.
In the course of 6 months, you will team up with us to crystallize your solution, perfect your product-market-fit, validate its efficacy and prepare the next stage of your venture build-up.
PlayBeyondBio is the fast track to integrating digital health solutions
in healthcare markets worldwide
3 DAY FACE TO FACE
MEETING WITH TOP 15
What do I get
Leverage AstraZeneca’s global expertise in the realms of science, regulation, medical and go-to-market
Work with experts on your proof of concept development and test it within our partners’ network of healthcare systems, government bodies, tech companies, academia and others
Receive JVP’s hands-on support on roadmap, venture building and business strategy, with the potential to obtain funding from JVP and partners down the road
Access to various types of clinical datasets
Top-notch mentors to brainstorm any issue
Assistance in finding key hires
Support from Microsoft for Startups, including solutions architecture, cloud credits and other goodies
We’re looking for innovators that aim to disrupt multiple clinical fields within the following therapeutic areas: Oncology and Hemato Oncology, Respiratory, Cardiovascular, Renal and Metabolic diseases. We’re also interested in additional therapeutic areas and non-clinically-specific platforms, so don’t hesitate to submit your application.
Key unmet needs we’re looking to address
Driving earlier, more accurate diagnosis at scale
Supporting patients, physicians and caregivers in managing and monitoring complex and chronic health conditions
Redesigning clinical pathways to generate better patient outcomes
Delivering improved quality of life to patients in a sustainable way
Enablers we find particularly compelling
Improving communications between all parties involved in the care process
Raising awareness and providing education to patients and health care professionals
Driving health system efficiency
Personalized content and automation
AI and big data, including NLP, computer vision and AR/VR
Established initial team
Willingness to collaborate on defining and building a 6-month project (e.g. Pilot/POC)
Less than $10m raised
Committed to participating in program activities